-
Sponsor Type
-
Federal
-
Country
-
United States
-
Grant Types
-
Research Project
Workshop/Conference
Collaboration/Cooperative Agreement
Last modified on 2020-03-24 23:38:16
Description
Effective March 31, 2019, FDA began operational implementation of an agency reorganization. FDA’s reorganization reflects the agency’s commitment to modernizing its structure to advance its mission to protect and promote public health, and to meet the challenges of rapid innovation across the industries regulated by FDA. The FDA’s reorganization has realigned several entities across the agency to promote strategic priorities, and will elevate the role of the centers, offices and field forces.
Sponsor Relationship
Office of the Commissioner is a part of:
The following sponsors are parts of Office of the Commissioner:
Most Recent Grants from This Sponsor
Funding Opportunity Number: RFA-FD-24-038
Background
Promoting the development of safe and...
Funding Opportunity Number: RFA-FD-24-026
The Food and Drug Administration (FDA) is announcing...
Funding Opportunity Number: RFA-FD-24-015
The U.S. Food and Drug Administration (FDA) is...
Funding Opportunity Number: RFA-FD-24-022
1.A. Background
The FDA Office of Minority Health...
Deadline Approaching Grants
No grants from this sponsor have deadline within a month period.
